#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Greg Merril Email
How to contact Greg Merril
Join and see Greg's contact info for free!Current Roles
Employees:
62Revenue:
$4.8MAbout
Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. Two key components of APT's approach are 1) PhageBank™, a large and dynamically growing collection of bacteriophages or “phages†(viruses that attack specific targeted bacteria) and 2) an innovative rapid system for matching phage to patient-specific bacterial infections. In 2016 APT's approach achieved its first in-human success with the rescue of a critically ill MDR infected patent.Adaptive Phage Therapeutics Address
708 Quince Orchard RoadGaithersburg, MD
United States